Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life study.
Cordone I, Marchesi F, Masi S, Summa V, Pisani F, Merola R, Cigliana G, Orlandi G, Gumenyuk S, Palombi F, Romano A, Spadea A, Renzi D, Papa E, Canfora M, Conti L, Petti MC, Mengarelli A. Cordone I, et al. Among authors: canfora m. J Exp Clin Cancer Res. 2016 Mar 19;35:49. doi: 10.1186/s13046-016-0324-0. J Exp Clin Cancer Res. 2016. PMID: 26992692 Free PMC article.
Flow cytometry characterization in central nervous system and pleural effusion multiple myeloma infiltration: an Italian national cancer institute experience.
Marchesi F, Masi S, Summa V, Gumenyuk S, Merola R, Orlandi G, Cigliana G, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, De Bellis F, Conti L, Mengarelli A, Cordone I. Marchesi F, et al. Among authors: canfora m. Br J Haematol. 2016 Mar;172(6):980-2. doi: 10.1111/bjh.13549. Epub 2015 Jun 17. Br J Haematol. 2016. PMID: 26081466 Free article. No abstract available.
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
Renzi D, Marchesi F, De Angelis G, Elia L, Salvatorelli E, Gumenyuk S, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Arcese W, Mengarelli A; Rome Transplant Network. Renzi D, et al. Among authors: canfora m. Chemotherapy. 2017;62(1):58-61. doi: 10.1159/000448750. Epub 2016 Sep 10. Chemotherapy. 2017. PMID: 27618144 Free article.
Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant.
Mengarelli A, Annibali O, Pimpinelli F, Riva E, Gumenyuk S, Renzi D, Cerchiara E, Piccioni L, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Cordone I, Canfora M, Arcese W, Ensoli F, Marchesi F. Mengarelli A, et al. Among authors: canfora m. J Infect. 2016 Feb;72(2):265-8. doi: 10.1016/j.jinf.2015.11.005. Epub 2015 Dec 12. J Infect. 2016. PMID: 26687516 No abstract available.
Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D, Franceschini L, Caffarella G, Rizzo M, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Pignatelli A, Cantonetti M, Arcese W, Mengarelli A. Marchesi F, et al. Among authors: canfora m. Bone Marrow Transplant. 2017 Jan;52(1):154-156. doi: 10.1038/bmt.2016.207. Epub 2016 Aug 15. Bone Marrow Transplant. 2017. PMID: 27526285 Clinical Trial. No abstract available.
BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.
Marchesi F, Capria S, Giannarelli D, Trisolini SM, Ansuinelli M, Caputo MD, Serrao A, Gumenyuk S, Renzi D, Pupo L, Palombi F, Provenzano I, Di Rocco A, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Cantonetti M, Mengarelli A. Marchesi F, et al. Among authors: canfora m. Bone Marrow Transplant. 2018 Aug;53(8):1051-1054. doi: 10.1038/s41409-018-0120-x. Epub 2018 Feb 13. Bone Marrow Transplant. 2018. PMID: 29440737 No abstract available.
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
Marchesi F, Vacca M, Giannarelli D, Ipsevich F, Pandolfi A, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Pierelli L, Mengarelli A. Marchesi F, et al. Among authors: canfora m. Transfusion. 2018 May;58(5):1143-1148. doi: 10.1111/trf.14533. Epub 2018 Feb 15. Transfusion. 2018. PMID: 29446445 Clinical Trial.
Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
Marchesi F, Vacca M, Gumenyuk S, Pandolfi A, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Ipsevich F, Santinelli S, De Rienzo M, Papa E, Canfora M, Laurenzi L, Foddai ML, Pierelli L, Mengarelli A. Marchesi F, et al. Among authors: canfora m. Leuk Lymphoma. 2016 Feb;57(2):489-492. doi: 10.3109/10428194.2015.1063147. Epub 2015 Jul 18. Leuk Lymphoma. 2016. PMID: 26099572 No abstract available.
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Ciliberto G, Canfora M, Terrenato I, Agnoletto C, Agustoni F, Amoroso L, Baldassarre G, Curigliano G, Delmonte A, De Luca A, Fiorentino M, Gregorc V, Ibrahim T, Lazzari C, Mastronuzzi A, Pronzato P, Santoro A, Scambia G, Tommasi S, Vingiani A, Giacomini P, De Maria R. Ciliberto G, et al. Among authors: canfora m. J Exp Clin Cancer Res. 2022 Oct 17;41(1):305. doi: 10.1186/s13046-022-02512-0. J Exp Clin Cancer Res. 2022. PMID: 36245005 Free PMC article.
41 results